{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:55:18Z","timestamp":1780628118051,"version":"3.54.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T00:00:00Z","timestamp":1591660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T00:00:00Z","timestamp":1591660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s12185-020-02909-7","type":"journal-article","created":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T16:19:17Z","timestamp":1591719557000},"page":"728-733","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Myelodysplastic syndromes in a pediatric patient with Cri du Chat syndrome with a ring chromosome 5"],"prefix":"10.1007","volume":"112","author":[{"given":"Akifumi","family":"Nozawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Ozeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiho","family":"Yasue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saori","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Kadowaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asahito","family":"Hama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Fukao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,9]]},"reference":[{"key":"2909_CR1","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1182\/blood-2017-09-765214","volume":"131","author":"F Locatelli","year":"2018","unstructured":"Locatelli F, Strahm B. How I treat myelodysplastic syndromes of childhood. Blood. 2018;131:1406\u201314.","journal-title":"Blood"},{"key":"2909_CR2","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/ajh.24930","volume":"93","author":"G Montalban-Bravo","year":"2018","unstructured":"Montalban-Bravo G, Garcia-Manero G. Myelodysplastic syndromes: 2018 update on diagnosis, risk-stratification and management. Am J Hematol. 2018;93:129\u201347.","journal-title":"Am J Hematol"},{"key":"2909_CR3","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/bjh.13915","volume":"172","author":"AM Cseh","year":"2016","unstructured":"Cseh AM, Niemeyer CM, Yoshimi A, et al. Therapy with low-dose azacitidine for MDS in children and young adults: a retrospective analysis of the EWOG-MDS study group. Br J Haematol. 2016;172:930\u20136.","journal-title":"Br J Haematol"},{"key":"2909_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1750-1172-1-33","volume":"1","author":"MP Cerruti","year":"2006","unstructured":"Cerruti MP. Cri du Chat syndrome. Orphanet J Rare Dis. 2006;1:33.","journal-title":"Orphanet J Rare Dis"},{"key":"2909_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.9734\/IBRR\/2014\/6978","volume":"2","author":"J Ai","year":"2014","unstructured":"Ai J, Visconte V, Rogers HJ, et al. Pure red cell aplasia in a patient with Cri-Du-Chat. Int Blood Res Rev. 2014;2:23\u20138.","journal-title":"Int Blood Res Rev"},{"key":"2909_CR6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/his.13721","volume":"74","author":"H Iwafuchi","year":"2019","unstructured":"Iwafuchi H, Ito M. Differences in the bone marrow histology between childhood myelodysplastic syndrome with multilineage dysplasia and refractory cytopenia of childhood without multilineage dysplasia. Histopathology. 2019;74:239\u201347.","journal-title":"Histopathology"},{"key":"2909_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1053\/j.seminhematol.2017.06.003","volume":"54","author":"C Talati","year":"2017","unstructured":"Talati C, Sallman D, List A. Lenalidomide: myelodysplastic syndromes with del(5q) and beyond. Semin Hematol. 2017;54:159\u201366.","journal-title":"Semin Hematol"},{"key":"2909_CR8","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.3324\/haematol.2013.091165","volume":"99","author":"H Sakaguchi","year":"2014","unstructured":"Sakaguchi H, Nishio N, Hama A, Kawashima N, et al., Japan Childhood Aplastic Anemia Study Group. Peripheral blood lymphocyte telomere length as a predictor of response to immunosuppressive therapy in childhood aplastic anemia. Haematologica. 2014;99:1312\u20136.","journal-title":"Haematologica"},{"key":"2909_CR9","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1016\/j.clml.2017.11.007","volume":"18","author":"PR Colunga-Pedraza","year":"2018","unstructured":"Colunga-Pedraza PR, Colunga-Pedraza JE, Garza-Ledezma MA, et al. Danazol as first-line therapy for myelodysplastic syndrome. Clin Lymphoma Myeloma Leuk. 2018;18:e109\u2013e113113.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2909_CR10","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/leu.2013.336","volume":"28","author":"T Haferlach","year":"2014","unstructured":"Haferlach T, Nagata Y, Grossmann V, et al. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia. 2014;28:241\u20137.","journal-title":"Leukemia"},{"key":"2909_CR11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ajhg.2013.01.015","volume":"92","author":"S Kunishima","year":"2013","unstructured":"Kunishima S, Okuno Y, Yoshida K, et al. ACTN1 mutations cause congenital macrothrombocytopenia. Am J Hum Genet. 2013;92:431\u20138.","journal-title":"Am J Hum Genet"},{"key":"2909_CR12","doi-asserted-by":"publisher","first-page":"15050","DOI":"10.1038\/hgv.2015.50","volume":"2","author":"Y Yamaguchi-Kabata","year":"2015","unstructured":"Yamaguchi-Kabata Y, Nariai N, Kawai Y, et al. iJGVD: an integrative Japanese genome variation database based on whole-genome sequencing. Hum Genome Var. 2015;2:15050.","journal-title":"Hum Genome Var"},{"key":"2909_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1136\/jmg.2006.045906","volume":"44","author":"RE Ferner","year":"2007","unstructured":"Ferner RE, Huson SM, Thomas N, et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet. 2007;44:81\u20138.","journal-title":"J Med Genet"},{"key":"2909_CR14","doi-asserted-by":"publisher","first-page":"e2015035","DOI":"10.4084\/mjhid.2015.035","volume":"7","author":"R Invernizzi","year":"2015","unstructured":"Invernizzi R, Quaglia F, Porta MG. Importance of classical morphology in the diagnosis of myelodysplastic syndrome. Mediterr J Hematol Infect Dis. 2015;7:e2015035.","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"2909_CR15","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1086\/374565","volume":"72","author":"A Zhang","year":"2003","unstructured":"Zhang A, Zheng C, Hou M, et al. Deletion of the telomerase reverse transcriptase gene and haploinsufficiency of telomere maintenance in Cri du chat syndrome. Am J Hum Genet. 2003;72:940\u20138.","journal-title":"Am J Hum Genet"},{"key":"2909_CR16","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1101\/gad.11.23.3109","volume":"11","author":"L Harrington","year":"1997","unstructured":"Harrington L, Zhou W, McPhail T, et al. Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev. 1997;11:3109\u201315.","journal-title":"Genes Dev"},{"key":"2909_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3390\/genes7090061","volume":"7","author":"J Ropio","year":"2016","unstructured":"Ropio J, Merlio JP, Soares P, Chevret E. Telomerase activation in hematological malignancies. Genes (Basel). 2016;7:61.","journal-title":"Genes (Basel)"},{"key":"2909_CR18","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.arr.2013.03.003","volume":"12","author":"FP Hartwig","year":"2013","unstructured":"Hartwig FP, Collares T. Telomere dysfunction and tumor suppression responses in dyskeratosis congenita: balancing cancer and tissue renewal impairment. Ageing Res Rev. 2013;12:642\u201352.","journal-title":"Ageing Res Rev"},{"key":"2909_CR19","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ejmg.2005.12.004","volume":"49","author":"PC Mainardi","year":"2006","unstructured":"Mainardi PC, Pastore G, Castronovo C, et al. The natural history of Cri du Chat Syndrome. A report from the Italian Register. Eur J Med Genet. 2006;49:363\u201383.","journal-title":"Eur J Med Genet"},{"key":"2909_CR20","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1136\/jmg.37.12.967","volume":"37","author":"C Perfumo","year":"2000","unstructured":"Perfumo C, Cerruti Mainardi P, Cali A, et al. The first three mosaic cri du chat syndrome patients with two rearranged cell lines. J Med Genet. 2000;37:967\u201372.","journal-title":"J Med Genet"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-020-02909-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-020-02909-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-020-02909-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T07:09:50Z","timestamp":1623222590000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-020-02909-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,9]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["2909"],"URL":"https:\/\/doi.org\/10.1007\/s12185-020-02909-7","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,9]]},"assertion":[{"value":"29 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest or funding to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional guidelines on human experimentation (Akifumi Nozawa, Michio Ozeki, Shiho Yasue, Saori Endo, Tomonori Kadowaki, Hidenori Ohnishi, Hideki Muramatsu, Asahito Hama, Yoshiyuki Takahashi, Seiji Kojima, and Toshiyuki Fukao) and with the Helsinki Declaration of 1975, as revised in 2008.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from the patient's parents for submission of this case report and any accompanying images.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}